Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/VERTEX-PHARMACEUTICALS-IN-11321/attualita/Vertex-Pharmaceuticals-Incorporated-fa-avanzare-Inaxaplin-VX-147-nella-porzione-di-Fase-3-dello-st-46338221/?utm_source=whatsapp&utm_medium=social&utm_campaign=share